Short Interest in Coloplast A/S (OTCMKTS:CLPBY) Grows By 26.9%

Coloplast A/S (OTCMKTS:CLPBY) saw a significant growth in short interest in the month of February. As of February 28th, there was short interest totalling 77,000 shares, a growth of 26.9% from the February 13th total of 60,700 shares. Based on an average daily trading volume, of 268,300 shares, the days-to-cover ratio is presently 0.3 days.

Wall Street Analyst Weigh In

Several analysts have recently commented on the stock. Sanford C. Bernstein upgraded shares of Coloplast A/S from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 28th. UBS Group upgraded shares of Coloplast A/S from a “strong sell” rating to a “hold” rating in a research report on Wednesday, December 11th. Finally, Royal Bank of Canada upgraded shares of Coloplast A/S from a “hold” rating to a “moderate buy” rating in a research report on Monday, March 3rd.

Coloplast A/S Trading Down 0.1 %

OTCMKTS:CLPBY opened at $10.61 on Wednesday. The company has a quick ratio of 0.66, a current ratio of 1.02 and a debt-to-equity ratio of 0.92. Coloplast A/S has a fifty-two week low of $10.43 and a fifty-two week high of $14.14. The firm’s 50 day moving average is $11.06 and its two-hundred day moving average is $12.05.

Coloplast A/S (OTCMKTS:CLPBY) last issued its earnings results on Tuesday, February 4th. The company reported $0.07 EPS for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.01). Coloplast A/S had a net margin of 17.81% and a return on equity of 28.60%. On average, equities research analysts predict that Coloplast A/S will post 0.31 earnings per share for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.